The company's S-1 lays the groundwork for what is widely expected to be one of the largest initial public offerings of the year, second only to Uber's IPO in May. It's also...Technologyread more
Fraud investigator Harry Markopolos' accusations extended beyond GE's management to actuaries, auditors and analysts who he claims overlooked billions in liabilities.Marketsread more
Trump's tweet comes a day after Apple put out a press release describing the money it spends on U.S.-based suppliers and vendors.Technologyread more
CNBC combed through Wall Street research to see which stocks are still a buy after their earnings reports.Marketsread more
President Donald Trump held a call on Wednesday with the CEOs of three major U.S. banks, according to people with knowledge of the situation.Marketsread more
Despite aggressive strides, Waymo needs one thing before their self-driving cars become a seriously useful transportation system: people. We talked to the ones closest to it.Technologyread more
Scientists say the smoke plumes, filled with megatons of tiny, harmful particles, could travel to other areas of the world and cause serious respiratory problems for people.Weather & Natural Disastersread more
Some Weight Watchers loyalists applaud Kurbo by WW. But nutritionists worry Kurbo promotes an unhealthy relationship with food during an especially impressionable time.Health and Scienceread more
Benefits from what President Trump called "the biggest reform of all time" to the tax code have dwindled to a faint breeze just 20 months after its enactment, writes John...Politicsread more
Epstein, 66, was found in his cell in Manhattan federal lockup Saturday morning and transferred to a nearby hospital, where he was subsequently pronounced dead.Politicsread more
Air travelers faced delays at U.S. airports on Friday afternoon after a computer issue snarled processing of international arrivals.Airlinesread more
At the end of every year, investment fund Rock Health asks the venture and start-up community to vote on the top digital health IPO of the year.
In 2017, Tabula Rasa Healthcare won -- even though the company actually went public in September 2016. It was such a drought that Rock Health couldn't find a single nominee for the calendar year.
Tabula Rasa, which is focused on medication safety, almost doubled in value last year, but still has a market capitalization well south of $1 billion.
Will the industry fare any better in 2018?
With investors gathered in San Francisco for the annual J.P. Morgan Healthcare conference, the industry's biggest event of the year, CNBC asked a dozen investors for their take.
Nina Kjellson, a health investor with Canaan Partners, doesn't expect to see more than three digital health IPO's in 2018. She said there's a deep malaise surrounding the lack of public offerings last year, a higher bar for IPOs and a lack of contenders that are far enough along in terms of revenue and partnerships.
Kjellson polled the audience at this week's conference to name a single start-up that could file in the next two quarters.
"An audience member said they may have one, but otherwise the room was crickets," she said.
Investors said digital health companies considering an IPO need about $100 million in annual recurring revenue, and the vast majority aren't there.
"The public market wants to see three to four quarters of predictable sales and ideally moving towards or at profitability," said Canaan's Julie Papanek. "Very few companies are pacing like that right now."
However, there are plenty of opportunities to get acquired.
"M&A is the new IPO," said Bill Evans, Rock Health's managing director, who closely tracks the industry.
But who will be the buyers of digital health companies in 2018?
Some investors are betting on big pharma. Companies like Merck and Johnson & Johnson are increasingly talking up machine learning and artificial intelligence. Digital health companies, particularly those focused on clinical trial matching or that track how patients are responding to treatments, could be prime targets.
Other venture capitalists, like Bessemer Venture Partners' Steve Kraus and Norwest Venture Partners' Robert Mittendorff, said that tech giants Alphabet, IBM, Apple and Microsoft will start to acquire digital health start-ups. UnitedHealth's Optum business, which describes itself as technology-enabled services, is also expected to make some strategic bets in the digital health sector.
These acquisitions could result in a more active IPO pipeline for next year.
"If they (tech companies) make a real big splash with some kind of acquisition, this could crack open the IPO markets and public market investor interest in the space sooner than maybe any of us think," suggested Kraus.
For most investors, 2019 holds more promise.
Investors named a handful of companies including Health Catalyst, Welltok, American Well, Grand Rounds Health, GoodRx, Oscar Health, Doximity and Zocdoc that they see entering the public markets by then.
Growth will be fueled by "robust business development deals among life sciences, medical device, payer, provider, employer, consumer and tech companies with leading digital health companies," said Flare Capital's Bill Geary.
Those types of deals mean real revenue, rather than just hype.